These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3602933)

  • 1. Human alveolar macrophages synthesize active complement components C6, C7, and C8 in vitro.
    Pettersen HB; Johnson E; Hetland G
    Scand J Immunol; 1987 Jun; 25(6):567-70. PubMed ID: 3602933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro.
    Johnson E; Hetland G
    Scand J Immunol; 1991 Jun; 33(6):667-71. PubMed ID: 2047760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro.
    Hetland G; Johnson E; Aasebø U
    Scand J Immunol; 1986 Nov; 24(5):603-8. PubMed ID: 3787189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex.
    Hetland G; Johnson E; Falk RJ; Eskeland T
    Scand J Immunol; 1986 Oct; 24(4):421-8. PubMed ID: 3764345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of complement by alveolar macrophages from patients with sarcoidosis.
    Pettersen HB; Johnson E; Mollnes TE; Garred P; Hetland G; Osen SS
    Scand J Immunol; 1990 Jan; 31(1):15-23. PubMed ID: 1689072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of the terminal complement proteins, C5-C9, by human platelets.
    Houle JJ; Leddy JP; Rosenfeld SI
    Clin Immunol Immunopathol; 1989 Mar; 50(3):385-93. PubMed ID: 2917425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblasts.
    Garred P; Hetland G; Mollnes TE; Stoervold G
    Scand J Immunol; 1990 Nov; 32(5):555-60. PubMed ID: 2270435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional active complement components secreted by guinea pig peritoneal macrophages.
    Brade V; Kreuzpaintner G
    Immunobiology; 1982 Apr; 161(3-4):315-21. PubMed ID: 7047377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of complement.
    Colten HR
    Adv Immunol; 1976; 22():67-118. PubMed ID: 769502
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    Joiner KA; Hammer CH; Brown EJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mRNA for the terminal complement components C5, C6, C8 and C9 in human umbilical vein endothelial cells in vitro.
    Langeggen H; Berge KE; Macor P; Fischetti F; Tedesco F; Hetland G; Berg K; Johnson E
    APMIS; 2001 Jan; 109(1):73-8. PubMed ID: 11297196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
    Zimmerman TS; Kolb WP
    J Clin Invest; 1976 Jan; 57(1):203-11. PubMed ID: 812888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of soluble C3 and C9 neoepitopes by human alveolar macrophages in vitro.
    Pettersen HB; Johnson E; Mollnes TE; Garred P
    Scand J Immunol; 1988 Oct; 28(4):431-4. PubMed ID: 2461585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
    Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
    J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogenetic analysis of the homologous proteins of the terminal complement complex supports the emergence of C6 and C7 followed by C8 and C9.
    Mondragón-Palomino M; Piñero D; Nicholson-Weller A; Laclette JP
    J Mol Evol; 1999 Aug; 49(2):282-9. PubMed ID: 10441679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
    Kitamura H; Tsuboi M; Nagaki K
    Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive method to detect synthesis of the functional classical, alternative and terminal pathway of complement by cells cultured in vitro.
    Johnson E; Hetland G
    Scand J Clin Lab Invest; 1988 May; 48(3):223-31. PubMed ID: 3287591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin and the terminal complement pathway synthesized by human umbilical vein endothelial cells are closely linked when detected on co-cultured agarose beads.
    Berge V; Johnson E; Høgåsen K
    APMIS; 1997 Jan; 105(1):17-24. PubMed ID: 9063496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.